Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Michael J. Fox Foundation

Investor type Incubator
Founders Deborah Brooks

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 37
Average round size
info
The average size of a deal this fund participated in
$17M
Portfolio companies 33
Rounds per year 1.68
Lead investments 5
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.11
Exits 12
Key employees Soon
Stages of investment
Grant

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Pharmaceutical
  • Medical
Summary

In 2000 was created Michael J. Fox Foundation, which is appeared as Corporate Investor. The fund was located in North America if to be more exact in United States. The main office of represented Corporate Investor is situated in the New York.

Among the most successful fund investment fields, there are Health Diagnostics, Health Care. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - Switzerland. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Addex Therapeutics, Inflazome, Ceregene.

This organization was formed by Deborah Brooks.

The top activity for fund was in 2017. Despite it in 2019 the fund had an activity. The increased amount of exits for fund were in 2016. Considering the real fund results, this Corporate Investor is 37 percentage points more often commits exit comparing to other organizations. Deals in the range of 1 - 5 millions dollars are the general things for fund. The fund is constantly included in less than 2 investment rounds annually. Opposing the other organizations, this Michael J. Fox Foundation works on 0 percentage points less the average amount of lead investments.

The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Michael J. Fox Foundation, startups are often financed by MPM Capital, Third Rock Ventures, Sofinnova Partners. The meaningful sponsors for the fund in investment in the same round are Wellcome Trust, Agentschap NL. In the next rounds fund is usually obtained by Seventure Partners, Janke Dittmer, INKEF Capital.

Read more

Funds with similar focus

Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Atreides Ventures -
BKW Bern, Bern, Switzerland
CEPCO -
Eclo Capital -
Enza Capital Kenya, Nairobi, Nairobi Area
eVisibility California, San Diego, United States
Excite New York, New York, United States
Green Cow Venture Capital California, San Francisco, United States
GRUPO BANCOLOMBIA Antioquia, Colombia, Medellín
Impact Capital New York, Pittsford, United States
iSME County Dublin, Dublin, Ireland
J-Angels California, Kentucky, United States
Lorito Holdings -
MOV Investimentos -
New Meadows Capital California, Saratoga, United States
New Wheel Capital -
Nueva Ventures California, San Mateo, United States
Ogaki Kyoritsu Bank Gifu Prefecture, Japan, Ogaki
Peninsula Ventures California, San Mateo, United States
TGVest Capital Taipei, Taiwan

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Koneksa Health

Analytics
Big Data
Health Care
16 Jun 2022 New York, New York, United States

Alzprotect

Biotechnology
Clinical Trials
Medical
Pharmaceutical
$338K01 Jun 2022 Maryland, United States

Asceneuron

Biotechnology
Health Care
Therapeutics
04 May 2022 Lausanne, Vaud, Switzerland

ND BioSciences

Biotechnology
Life Science
18 Jan 2022 Epalinges, Vaud, Switzerland

Arkuda Therapeutics

Biotechnology
Health Care
Pharmaceutical
Therapeutics
06 Dec 2021 Cambridge, Massachusetts, United States

MISSION Therapeutics

Biotechnology
Health Care
Life Science
Therapeutics
$500K12 Oct 2021 Cambridge, England, United Kingdom

NRG Therapeutics

Biotechnology
$500K29 Jul 2021 Cambridge, Cambridgeshire, United Kingdom

Wealthsimple

Finance
Financial Services
FinTech
Impact Investing
Personal Finance
$596M03 May 2021 Old Toronto, Ontario, Canada

MapLight Therapeutics

Biopharma
Biotechnology
Life Science
Medical
$8M30 Nov 2020 Palo Alto, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Michael J. Fox Foundation?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: